The core of Dexa Group
Dexa Group has been built on continual innovation. For fifty years, we have researched, developed, and distributed outstanding drugs that have helped millions. Apart from industry-leading pharmaceutical formulations, we also work on other innovations, such as the development of herbal drugs and of new drug delivery systems. Our research has yielded dozens of popular products that are used and patented all over the world.
Dexa Laboratories of Biomolecular Sciences (DLBS) is a group of research institutions for the discovery, development and production of pharmaceuticals, bio-pharmaceuticals, and nutraceuticals.
Since its inception in 2005, DLBS has helped research, extract, and utilise natural ingredients, principally as bioactive ingredients in modern herbal medicines. In fact, all modern herbal medicines produced by Dexa Group have been researched by DLBS at its facilities in Indonesia. DLBS leverages Indonesia’s rich biodiversity, extracting bioactive ingredients from many life forms and other organic substances.
DLBS is home to some of the world’s most talented scientists and pharmacists. It also collaborates with — and trains — farmers to produce high-quality, standardized, natural ingredients. In this way, it continues to add value to the local ecosystem.
DLBS research meets, and often exceeds, the highest standards of scientific rigour, and all its products are equipped with strong molecular and clinical evidence. The group frequently collaborates with partner research centres all over the world, including with highly-regarded institutions of excellence in dozens of countries around the world, including the United States, Singapore, and Indonesia.
“The establishment of DLBS is the realisation of my dream for this nation to become a major player in the research and development of new drugs. Through research, we must be able to extract materials from Indonesian soil, manage them into medicine dedicated to humanity, not only at the Indonesian level but also throughout the world.”
(Late) Dr. Rudy Soetikno
Lt. Col. (Retd.), Health and Medical Corps,
Indonesian Armed Forces
New product development work, the backbone of Dexa Group, is consolidated at the Dexa Development Center, a state-of-the-art two-hectare space for the Group’s drug discovery and formulation activities. This crucial work is carried out by large, experienced research teams with a proven track record of developing highly efficacious and marketable products. The Dexa Development Center has also been a key contributor in more than ten successful alliances with global leaders in pharmaceutical research.